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Ag-doped nanocrystalline hydroxyapatite nanoparticles (Ag:HAp-NPs) (Ca10-xAgx(PO4)6(OH)2, xAg = 0.05, 0.2, and 0.3)
with antibacterial properties are of great interest in the development of new products. Coprecipitation method is a
promising route for obtaining nanocrystalline Ag:HAp with antibacterial properties. X-ray diffraction identified HAp
as an unique crystalline phase in each sample. The calculated lattice constants of a= b= 9.435 Å, c= 6.876 Å for
xAg = 0.05, a= b= 9.443 Å, c= 6.875 Å for xAg = 0.2, and a= b= 9.445 Å, c= 6.877 Å for xAg = 0.3 are in good
agreement with the standard of a= b= 9.418 Å, c= 6.884 Å (space group P63/m). The Fourier transform infrared and
Raman spectra of the sintered HAp show the absorption bands characteristic to hydroxyapatite. The Ag:HAp
nanoparticles are evaluated for their antibacterial activity against Staphylococcus aureus, Klebsiella pneumoniae,
Providencia stuartii, Citrobacter freundii and Serratia marcescens. The results showed that the antibacterial activity
of these materials, regardless of the sample types, was greatest against S. aureus, K. pneumoniae, P. stuartii, and
C. freundii. The results of qualitative antibacterial tests revealed that the tested Ag:HAp-NPs had an important
inhibitory activity on P. stuartii and C. freundii. The absorbance values measured at 490 nm of the P. stuartii and
C. freundii in the presence of Ag:HAp-NPs decreased compared with those of organic solvent used (DMSO) for
all the samples (xAg = 0.05, 0.2, and 0.3). Antibacterial activity increased with the increase of xAg in the samples.
The Ag:HAp-NP concentration had little influence on the bacterial growth (P. stuartii).
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In the last years, nanocomposites have received consid-
erable attention due to their unique chemical and phys-
ical properties such as nanometric sizes, high surface
area, and high reactivity. Nanoparticles have been suc-
cessfully used in fields like electronics, optics, biology,
chemistry, environment, and medicine [1,2].
Pharmaceutical companies and research communities
are searching for new antibacterial agents [3] due to
the outbreak of infectious diseases caused by microor-
ganisms and the lack of efficient antibiotics. It seems
that the answer towards developing new antibacterial
agents lies within the research area of nanoscale* Correspondence: dpredoi@gmail.com
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in any medium, provided the original work is pmaterials. The applications of nanoscale materials have
increased considerably. Nanomaterials have also been
used in nanochemistry to enhance the immobilization
and activity of catalysts [4]; in medical and pharma-
ceutical nanoengineering, for delivery of therapeutic
agents [5]; in chronic disease diagnostics, sensors, and
the food industry, to limit bacterial growth [6-10]. The
need for constantly developing new drugs and drug
targets is due to the unique property of microorgan-
isms to adapt to harsh conditions and, implicitly, to
new drugs. In the last decade, the pharmaceutical
companies have introduced only few new antibiotics,
and none of them demonstrated improvements against
multidrug-resistant bacteria [11]. As an alternative to
classical antibiotics, nanoparticles with antibacterial
properties are on the top of the scientific research
current topics. One of the most known and usedan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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years is silver [12,13]. Although the exact mechanism
of silver is not known, it is currently used to control
bacterial growth in various applications such as dentis-
try, burn wounds, and catheters [14,15]. The anti-
microbial properties of silver depend on the cation, Ag
+, which has the ability to form a strong bond with
electron donor groups in biological molecules. The re-
search interest in this area of materials science is to
find an appropriate biomaterial and successfully embed
silver ions [16]. For that purpose, during the past 30
years, there has been a major advance in the develop-
ment of medical materials due to the innovation of
ceramic materials.
One of the most representative biomaterial based on
calcium phosphate is hydroxyapatite (HAp). Because of
its similar molecular composition to human bone, HAp
has been widely investigated for its bone regeneration
and bone-engineering applications [17-21]. Microorgan-
ism adhesions on implant surfaces represent an initial
crucial step in infections.
Previous studies have focused on preparation and
characterization of silver nanoparticles (AgNPs) [22].
The exact antibacterial action of AgNPs is not com-
pletely understood [23]. On the other hand, in the litera-
ture, the studies on the preparation and characterization
of the silver-doped HAp powders are almost absent. The
most recent studies [24] present preliminary antimicro-
bial research on the Ag:HAp nanopowder.
In this paper, we report the synthesis method for
obtaining silver-doped HAp with xAg = 0.05, 0.2, and 0.3.
The structure, morphology, vibrational, and optical
properties of the obtained samples were systematically
characterized by X-ray diffraction (XRD), transmission
electron microscopy (TEM), Fourier transform infrared
(FT-IR) and FT-Raman spectroscopies. Staphylococcus
aureus and Providencia stuartii bacterial strains are




All reagents for synthesis including ammonium dihy-
drogen phosphate [(NH4)2HPO4] (Alfa Aesar, Karls-
ruhe, Germany; 99.99% purity), calcium nitrate [Ca
(NO3)24H2O] (Alfa Aesar, Karlsruhe, Germany; 99.99%
purity), silver nitrate (AgNO3) (Alfa Aesar, Karlsruhe,
Germany; 99.99% purity), and ammonium hydroxide
(NH3) (25%, Alfa Aesar, Karlsruhe, Germany; 99.99%
purity) were used for the synthesis of hydroxyapatite
doped with silver.
Nanocrystalline hydroxyapatite doped with Ag
(Ca10−xAgx(PO4)6(OH)2, from xAg = 0.05 to xAg = 0.3)
was performed by setting the atomic ratio of Ag/[Ag +Ca] from 5% to 30% and [Ca + Ag]/P as 1.67. AgNO3
and Ca(NO3)24H2O were dissolved in deionized water
to obtain 300-ml [Ca +Ag]-containing solution. On
the other hand, (NH4)2HPO4 was dissolved in deio-
nized water to make a 300-ml P-containing solution.
The [Ca +Ag]-containing solution was put into a Ber-
zelius and stirred at 100°C for 30 min. Meanwhile, the
pH of the P-containing solution was adjusted to 10
with NH3 and stirred continuously for 30 min. The P-
containing solution was added drop by drop into the
[Ca + Ag]-containing solution and stirred for 2 h, and
the pH was constantly adjusted and kept at 10 during
the reaction. After the reaction, the deposited mixtures
were washed several times with deionized water. The
resulting material (Ag:HAp (xAg from 0.05 to 0.3)) was
dried at 100°C for 72 h.
Sample characterization
The XRD measurements for the Ca10−xAgx(PO4)6(OH)2
samples were recorded using a Bruker D8 Advance dif-
fractometer (BRUKER OPTIK GMBH, Karlsruhe, Ger-
many), with nickel-filtered CuKα (λ= 1.5418 Å)
radiation, and a high efficiency one-dimensional detector
(Lynx Eye type) operated in integration mode. The dif-
fraction patterns were collected in the 2θ range of 15° to
140°, with a step of 0.02° and a 34-s measuring time per
step. TEM studies were carried out using a FEI Tecnai 12
(FEI Company, Hillsboro, OR, USA) equipped with a
low-dose digital camera from Gatan Inc. (Pleasanton,
CA, USA). The specimen for TEM imaging was prepared
by ultramicrotomy to get a thin section of about 60 nm
in thickness. The powder is embedded in an epoxy resin
(polaron 612) before microtomy. The TEM modes used
were bright field (BF) and selected area diffractions. The
functional groups present in the prepared nanoparticles
and thin films were identified by FT-IR using a Spectrum
BX spectrometer (PerkinElmer Instruments, Branford,
CT, USA). To obtain the nanoparticle spectra, 1% of
nanopowder was mixed and ground with 99% KBr.
Tablets of 10 mm in diameter were prepared by pressing
the powder mixture at a load of 5 tons for 2 min. The
spectrum was taken in the range of 500 to 4,000 cm−1
with a 4-cm−1 resolution. Micro-Raman spectra on HAp
powders were performed in a backscattering geometry at
room temperature and in ambient air, under a laser exci-
tation wavelength of 514 nm, using a Jobin Yvon T64000
Raman spectrophotometer under a microscope.
The in vitro antibacterial activity
These nanoparticles were evaluated for their antibacter-
ial activity against gram-positive (Staphylococcus aureus)
and gram-negative (Providencia stuartii, Citrobacter
freundii, Klebsiella pneumoniae and Serratia marcescens)
bacteria.
Figure 1 Comparative representation of experimental XRD
patterns and hydroxyapatite characteristic lines according to
ICDD-PDF number 9–432.
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were determined against ATCC reference and clinical mi-
crobial strains, i.e., gram-positive (S. aureus ATCC 25293),
gram-negative (P. stuartii 1116, C. freundii 1748, K. pneu-
moniae ESBL, S. marcescens 0804) bacterial strains.
The microbial strain identification was confirmed by
aid of VITEK 2 (bioMérieux, Marcy l’Etoile, France).
VITEK is an integrated system that automatically per-
forms rapid identification using algorithms based on
fluorescence and colorimetry and antimicrobial suscepti-
bility testing based on kinetic analysis of growth data.
VITEK cards for identification and susceptibility testing
were inoculated and incubated according to the manu-
facturer’s recommendations. The results were inter-
preted using the software version AMS R09.1.
Microbial suspensions of 1.5 × 108 colony-forming unit
(CFU)/ml corresponding to 0.5 McFarland density
obtained from 15- to 18-h bacterial cultures developed
on solid media were used in our experiments. The tested
substances were solubilized in dimethyl sulfoxide
(DMSO), and the starting stock solution was of 5,000
μg/ml concentration. The qualitative screening was per-
formed by an adapted disk diffusion method [25-29].
The quantitative assay of the antimicrobial activity
against planktonic microbial strains was performed using
the liquid medium microdilution method, in 96-
multiwell plates, in order to establish the minimal in-
hibitory concentration (MIC). For this purpose, two fold
serial dilutions of the compounds ranging between 000
and 1.95 μg/ml were performed in a 200-μl volume of
broth, and each well was seeded with 50 μl of microbial
inoculum. Sterility control (wells containing only culture
medium) and culture controls (wells containing culture
medium seeded with the microbial inoculum) were used.
The influence of the DMSO solvent was also quantified
in a series of wells containing DMSO, diluted accord-
ingly with the dilution scheme used for the complexes.
The plates were incubated for 24 h at 37°C. The MIC
values were considered as the lowest concentration of
the tested compound that inhibited the visible growth of
the microbial overnight cultures [25-29].
The assessment of the complexes influence on the mi-
crobial ability to colonize an inert substratum was per-
formed using the microtiter method. For this purpose,
the microbial strains have been grown in the presence of
two fold serial dilutions of the tested compounds per-
formed in liquid nutrient broth/YPG, distributed in 96-
well plates and incubated for 24 h at 37°C for bacterial
strains and for 48 h at 28°C for fungal strains. At the
end of the incubation period, the plastic wells were emp-
tied, washed three times with phosphate buffered saline,
fixed with cold methanol, and stained with 1% violet
crystal solution for 30 min. The biofilm that formed on
plastic wells was resuspended in 30% acetic acid. Theintensity of the colored suspensions was assessed by
measuring the absorbance at 490 nm. The last concen-
tration of the tested compound that inhibited the devel-
opment of microbial biofilm on the plastic wells was
considered the minimum inhibitory concentration of
biofilm development and was also expressed in micro-
grams per milliliter [30-33].
Results and discussion
The XRD pattern of Ag:HAp (Ca10−xAgx(PO4)6(OH)2,
with xAg = 0.05, 0.2, and 0.3) powders are shown in
Figure 1. A typical XRD of HAp is demonstrated, which
closely matches the one of Ca10(PO4)6(OH)2, according
to the International Centre for Diffraction Data (ICDD),
Powder Diffraction File (PDF) standard card number 9–
432 represented at the bottom of the figure, as reference.
No other crystalline phases were detected besides this
phase (Figure 1). The XRD of Ag:HAp powders are simi-
lar to that of HAp, but the reduced intensity indicates
that the crystallinity decreases gradually with xAg from
0.05 to 0.3. The XRD of Ag:HAp also demonstrates that
powders obtained by coprecipitation exhibit the apatite
characteristics with good crystal structure and no new
phase or impurity. Insightful analyses of the doped HAp
structures, carried out by Rietveld whole powder pattern
fitting using the MAUD code [34], showed that Ag enters
the HAp lattice by substituting Ca, with comparable
probabilities for the two crystallographic sites of calcium
in the HAp unit cell. The lattice parameters did not mod-
ify significantly after substitution. The XRD analysis
using the anisotropic microstructure analysis implemen-
ted in MAUD as ‘Popa rules’ [35] show that the calcu-
lated lattice constants for Ag:HAp are in good agreement
with the standard data PDF file number 9–432. The
Figure 3 HRTEM image of Ag:HAp-NPs with xAg = 0.3.
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for xAg = 0.05, a= b= 9.443 Å, c= 6.875 Å for xAg = 0.2,
and a= b= 9.445 Å, c= 6.877 Å for xAg = 0.3 are in good
agreement with the standard of a= b= 9.418 Å, c= 6.884
Å (space group P63/m).
The TEM micrographies give information on the tex-
ture (BF) and the structure (SAED) of the three samples
(xAg = 0.05, 0.2, and 0.3). All the samples exhibit a uni-
form rod-like morphology with particles from 30 to 5
nm, as observed on the BF micrographies (Figure 2).
These results revealed that the doping components have
little influence on the surface morphology of the sam-
ples. The morphology identifications indicated that the
nanoparticles with good crystal structure could be made
using the coprecipitation method at low temperature. It
can be seen from the high-resolution TEM (HRTEM)
image of Ag:HAp-NPs with xAg = 0.3 (Figure 3) that the
crystalline phase of hydroxyapatite with well-resolved
lattice fringes can be observed. The distances (2.81 and
1.94 Å) between the adjacent lattice fringes agree well
with the d211 and d222 spacing from the literature values
(0.2814 and 0.194 nm; CJPDS no. 09–0432).
FT-IR spectroscopy was performed in order to investi-
gate the functional groups present in nano-hydroxyapatite,
Ca10−xAgx(PO4)6(OH)2 (xAg= 0.05, 0.2, and 0.3), obtained
at 100°C by coprecipitation method. Figure 4 shows
the FT-IR results obtained from Ag:HAp-NPs when xAgFigure 2 TEM micrographies of the Ag:HAp samples
synthesized with xAg = 0.05, 0.2, and 0.3.increases from 0.05 to 0.3. These data clearly revealed
the presence of various vibrational modes corresponding
to phosphates and hydroxyl groups. For all samples, the
presence of a strong OH vibration peak could be noticed.
The broad bands in regions 1,600 to 1,700 cm−1 and
3,200 to 3,600 cm−1 correspond to H-O-H bands of
water lattice [36-38].
Band characteristics of the phosphate and hydrogen
phosphate groups in apatitic environment were
observed: 563, 634, 603, 960 cm−1, and 1,000 to 1,100
cm−1 for the PO4
3− groups [39,40] and at 875 cm−1 for
the HPO4
2− ions [41]. Moreover, it should be noted that
the HPO4
2− band was present in all the spectra, but for
high values of xAg, the band diminished. A CO3
2− band
occurred in the spectra at 1,384 cm−1 [40].Figure 4 Transmittance infrared spectra of the Ag:HAp samples
synthesized with xAg = 0.05, 0.2, and 0.3.
Figure 5 Raman spectra of the Ag:HAp samples synthesized
with xAg = 0.05, 0.2, and 0.3.
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Raman spectroscopy (Figure 5). The internal modes of
the PO4
3− tetrahedral ν1 frequency (960 cm
−1) corre-
sponds to the symmetric stretching of P-O bonds.
The vibrational bands at 429 (ν2) and 450 cm
−1 (ν2)
are attributed to the O-P-O bending modes. We
assigned the bands present at 1,046 (ν3) and 1,074 cm
−1 (ν3) to asymmetric ν3 (P-O) stretching. The values
of ν4 (589 and 608 cm
−1) can be addressed mainly to
the O-P-O bending character [42]. However, intensity
of the vibration peak decreases when xAg increases.
The qualitative screening of the antimicrobial activity of
the tested compounds performed using stock solutions of
5 mg/ml obtained in DMSO allowed the selection of the
active compounds, indicated by the occurrence of growthFigure 6 Antibacterial activity of Ag:HAp-NPs (xAg = 0.05, 0.2, and 0.3inhibition zones around the spotted compound, with
higher diameters than those obtained for the DMSO solv-
ent. The specific antimicrobial activity revealed by the
qualitative assay is demonstrating that our compounds are
interacting differently with the microbial targets, probably
due to the differences in the microbial wall structures. For
the quantitative assays, the active compounds have been
tested only on the strains which proved to be sensitive in
the qualitative assays. It is also to be mentioned that
DMSO did not exhibit any traceable antimicrobial activity
at the studied concentrations; thus, the solvent did not in-
fluence the biological activity of the tested substances. The
inert substrate including the prosthetic medical devices
represents risk factors for the occurrence of biofilm-
associated infections.
These nanoparticles are evaluated for their antibac-
terial activity against gram-positive (S. aureus) and
gram-negative (P. stuartii, C. freundii, K. pneumoniae,
and S. marcescens) bacteria.
S. aureus is the most common organism associated
with infections. The reason that S. aureus is a successful
pathogen is because of a combination of bacterial
immuno-evasive strategies. It is still one of the five most
common causes of nosocomial infections and is often
the cause of postsurgical wound infections [43]. S. aur-
eus was inhibited for a Ag:HAp-NP concentration above
1.95 μg/ml for the samples with xAg = 0.2 and 0.3. For
the samples with xAg = 0.05, no significant antibacterial
activity was observed when the Ag:HAp-NP concentra-
tion was less than 250 μg/ml. For the samples with xAg =
0.2, the antibacterial activity increases to Ag:HAp-NP
concentrations lower than 250 μg/ml. For Ag:HAp-NP
concentrations greater than 250 μg/ml, we have a con-
stant antibacterial activity. In the samples with xAg = 0.3,) on S. aureus.
Figure 7 Antibacterial activity of Ag:HAp-NPs (xAg = 0.05, 0.2, and 0.3) on P. stuartii.
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of the antibacterial activity of different Ag:HAp-NPs are
presented in Figure 6.
Both P. stuartii and C. freundii are commonly found
in soil, water, and sewage [44]. P. stuartii [45] and C.
freundii [46] are responsible for a number of significant
opportunistic infections. Figures 7 and 8 show the
results of antibacterial activity of different Ag:HAp-NPs
exposed to P. stuartii and C. freundii, respectively.
The results of qualitative antibacterial tests revealed
that the tested Ag:HAp-NPs had an important inhibitory
activity on P. stuartii and C. freundii. The absorbance
values measured at 490 nm of P. stuartii and C. freundii
in the presence of Ag:HAp-NPs decreased compared
with that of the organic solvent used (DMSO) for all the
samples (xAg = 0.05, 0.2, and 0.3). Antibacterial activity
increased with the increase of xAg in the samples. The
Ag:HAp-NP concentration had little influence on bacter-
ial growth (P. stuartii).Figure 8 Antibacterial activity of Ag:HAp-NPs (xAg = 0.05, 0.2, and 0.3In recent years, K. pneumoniae has become an import-
ant pathogen in nosocomial infections. It naturally
occurs in the soil, and about 30% of strains can fix nitro-
gen in anaerobic conditions [47]. Figure 9 illustrated the
antibacterial activity of different values of xAg on K.
pneumoniae. It shows the inhibition of the bacteria
based on the antimicrobial activity of the organic solvent
used (DMSO). For samples with xAg = 0.2 and 0.3, the
antibacterial activity did not depended on the Ag:HAp-
NP concentration. For samples with xAg = 0.05, a slight
antibacterial activity was observed up to 31.25 μg/ml Ag:
HAp-NP concentration.
S. marcescens is differentiated from other gram-
negative bacteria by its ability to perform casein hy-
drolysis, which allows it to produce extracellular
metalloproteinases which are believed to function in
cell-to-extracellular matrix interactions [48]. The anti-
bacterial activity of the Ag:HAp nanoparticles on S. mar-
cescens can be seen in Figure 10. In the presence of) on C. freundii.
Figure 9 Antibacterial activity of Ag:HAp-NPs (xAg = 0.05, 0.2, and 0.3) on K. pneumoniae.
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were not observed, even in high concentrations of Ag:
Hap-NPs (500 and 1,000 μg/ml) for the samples with
xAg = 0.2 and 0.3.
Several studies demonstrated that silver nanoparticles
show an efficient antibacterial activity against Escheri-
chia coli and S. aureus [49-51]. Besides, a high concen-
tration of silver nanoparticles may cause adverse health
effects. For reducing the toxic effects of silver, several
biodegradable polymers were used for coating the silver
nanoparticles. Recent studies on Ag: Hap nanopowders
[26] obtained by coprecipitation method demonstrated a
good antibacterial activity. Novel nanopowders based on
silver-doped hydroxyapatite will diminish the adverse
effects of silver.
Based on the tests mentioned above, the results showed
that the antimicrobial activity of the Ag:HAp-NPs
depended strongly on xAg. The Ag:HAp-NP concentrations
were high enough to obtain a good antibacterial activity.
It was observed that the inhibition depends on theFigure 10 Antibacterial activity of Ag:HAp-NPs (xAg = 0.05, 0.2 and 0.3concentration of Ag:Hap-NPs in accord with the prece-
dent studies on Ag nanoparticles [52]. Our study showed
that Ag:HAp-NPs presents inhibitory effects on a large
number of gram-positive and gram-negative bacteria.
Conclusions
In this study, our aim was to illustrate good antibacterial
property of the silver-doped hydroxyapatite. Finally, it
was demonstrated that Ag:HAp-NPs possess excellent
antibacterial properties. Ag:HAp prepared by coprecipi-
tation method at low temperature shows great promise
as antibacterial agents against both gram-positive and
gram-negative bacteria. The Ag:HAp nanoparticles show
the efficient antibacterial activity against S. aureus, P.
stuartii, C. freundii, and K. pneumoniae. Antibacterial
activity increased with increasing xAg in the samples.
Antibacterial activity is also related to the concentration
of the Ag:HAp nanoparticles and the initial bacterial
concentration. In the presence of Ag:Hap, the growth in-
hibitory effects on S. marcescens were not observed,) on S. marcescens.
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Ag: HAp-NPs may find various practical applications
such as wound dressings or improving water quality.
Abbreviations
DMSO: dimethyl sulfoxide; FT-IR spectroscopy: Fourier transform infrared
spectroscopy; ICDD: International Centre for Diffraction Data; PDF: Powder
Diffraction File; TEM: transmission electron microscopy; XRD: X-ray diffraction.
Competing interests
The authors declare that they have no competing interests.
Acknowledgments
The authors would like to thank Florian Massuyeau (Institut des Matériaux-
Jean Rouxel, Nantes) and Professor Carmen Mariana Chifiriuc (Microbiology
Immunology Department, Faculty of Biology, University of Bucharest) for
their kind help in using the Raman device and for assistance with the
antimicrobial tests, as well as for their constructive discussions. This work was
financially supported by IFA-CEA program under project no: C2-06.
Author details
1National Institute of Materials Physics, 105 bis Atomistilor, P.O. Box MG 07,
Magurele Bucuresti 077125, Romania. 2University of Bordeaux, EA 4592
Géoressources & Environnement, EGID, 1 allée F. Daguin 18, Pessac Cedex
33607, France. 3Faculty of Physics, University of Bucharest, 405 Atomistilor, CP
MG - 1, Magurele, Bucuresti 077125, Romania.
Authors’ contributions
CSC and DP conceived the study. CSC, SLI, and LVC performed the synthesis
of the powders. Characterization of materials was carried out by CSC and DP.
TEM investigations were done by PLC. SLI performed the antibacterial
investigations. DP directed the study and wrote the draft paper. All authors
contributed to the interpretation of results and discussion, have corrected,
read, and approved the final manuscript.
Received: 29 March 2012 Accepted: 26 May 2012
Published: 21 June 2012
References
1. Morones JR, Elechiguerra JL, Camacho A, Ramirez JT: The bactericidal effect
of silver nanoparticles. Nanotechnology 2005, 16:2346–2353.
2. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH,
Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH: Antimicrobial effects of
silver nanoparticles. Nanomed Nanotechnol Biol Med 2007, 3:95–101.
3. Mahendra R, Alka Y, Aniket G: Silver nanoparticles as a new generation of
antimicrobials. Biotechnol Adv 2009, 27:76–83.
4. Wang P: Nanoscale biocatalyst systems. Curr Opinion Biotechnol 2006,
17:574–579.
5. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC:
Nanoparticles in medicine: therapeutic applications and developments.
Clin Pharmacol Ther 2008, 83:761–769.
6. Chau CF, Wu SH, Yen GC: The development of regulations for food
nanotechnology. Trends Food Sci Technol 2007, 18:269–280.
7. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya
RH: Functional finishing of cotton fabrics using silver nanoparticles.
J Nanosci Nanotechnol 2007, 7:1893–1897.
8. Jiang Wu, Lee S, Reddy VR, Manasreh MO, Weaver BD, Yakes MK, Kunets
VasP, Benamara M, Salamo GJ: Photoluminescence plasmonic
enhancement in In As quantum dots coupled to gold nanoparticles.
Mater Lett 2011, 65:3605–3608.
9. Lee S, Cho K, Lim J, Kim W, Hwang S: Acclimation and activity of
ammonia-oxidizing bacteria with respect to variations in zinc
concentration, temperature, and microbial population. Bioresource Technol
2011, 12(5):4196–4203.
10. Shin SG, Lee S, Lee C, Hwang K, Hwang S: Qualitative and quantitative
assessment of microbial community in batch anaerobic digestion of
secondary sludge. Bioresource Technol 2010, 101(24):9461–9470.
11. Conlon JM, Kolodziejek J, Nowotny N: Antimicrobial peptides from ranid
frogs: taxonomic and phylogenetic markers and a potential source of
new therapeutic agents. Biochim Biophys Acta 2004, 1696:1–14.12. Goodman LS, Gilman A: The pharmacological basis of therapeutics. 5th
edition. New York: Macmillan Publishing Co.; 1975.
13. Silver S, Phung LT: Bacterial heavy metal resistance: new surprises. Annu
Rev Microbiol 1996, 50:753–789.
14. Catauro M, Raucci MG, De Gaetano FD, Marotta A: Antibacterial and
bioactive silver containing Na2O CaO 2SiO2 glass prepared by sol–gel
method. J Mater Sci Mater Med 2004, 15(7):831–837.
15. Crabtree JH, Burchette RJ, Siddiqi RA, Huen IT, Handott LL, Fishman A: The
efficacy of silver-ion implanted catheters in reducing peritoneal
dialysis-related infections. Perit Dial Int 2003, 23(4):368–374.
16. Wohrmann RM, Munstedt H: Zur bestimmung der freisetzung von
silberionen aus silbergef ulltem polyurthan. Infection 1998, 26:49–52.
17. Xin R, Leng Y, Chen J, Zhang Q: A comparative study of calcium
phosphate formation on bioceramics in vitro and in vivo. Biomaterials
2005, 26(33):6477–6486.
18. Ramila A, Vallet-Regi M: Static and dynamic in vitro study of a sol–gel
glass bioactivity. Biomaterials 2001, 22(16):2301–2306.
19. Ragel CV, Vallet-Regi M, Rodriguez-Lorenzo LM: Preparation and in vitro
bioactivity of hydroxyapatite/solgel glass biphasic material. Biomaterials
2002, 23(8):1865–1872.
20. Fujibayashi S, Neo M, Kim HM, Kokubo T, Nakamura T: A comparative study
between in vivo bones ingrowth and in vitro apatite formation on
Na2O–CaO–SiO2 glasses. Biomaterials 2003, 24(8):1349–1356.
21. Siriphannon P, Kameshima Y, Yasumori A, Okada K, Hayashi S: Comparative
study of the formation of hydroxyapatite in simulated body fluid under
static and flowing systems. J Biomed Mater Res 2002, 60(1):175–185.
22. Sondi I, Salopek Sondi B: Silver nanoparticles as antimicrobial agent: a
case study on E. coli as a model for gram–negative bacteria. J Colloid
Interf Sci 2004, 275:177–182.
23. Li X, Li S, Zhang M, Zhang W, Li C: Evaluations of antibacterial activity and
cytotoxicity on Ag nanoparticles. Rare Metal Mat Eng 2011,
40(2):0209–0214.
24. Ciobanu CS, Massuyeau F, Constantin LV, Predoi D: Structural and physical
properties of antibacterial Ag doped nano-hydroxyapatite synthesized at
100°C. Nanoscale Res Lett 2011, 6:613.
25. Limban C, Chifiriuc MC: Antibacterial activity of new dibenzoxepinone
oximes with fluorine and trifluoromethyl group substituents. Int J Mol Sci
2011, 12(10):6432–6444.
26. Limban C, Marutescu L, Chifiriuc MC: Synthesis, spectroscopic properties
and antipathogenic activity of new thiourea derivatives. Molecules 2011,
16(9):7593–7607.
27. Saviuc C, Grumezescu AM, Holban A, Bleotu C, Chifiriuc CM, Balaure P, Lazar
V: Phenotypical studies of raw and nanosystem embedded Eugenia
carryophyllata buds essential oil antibacterial activity on Pseudomonas
aeruginosa and Staphylococcus aureus strains. Biointerface Res App Chem
2011, 1(3):111–118.
28. Chifiriuc MC, Palade R, Israil AM: Comparative analysis of disk diffusion
and liquid medium microdillution methods for testing the antibiotic
susceptibility patterns of anaerobic bacterial strains isolated from
intrabdominal infections. Biointerface Res App Chem 2011, 1(6):209–220.
29. Marutescu L, Limban C, Chifiriuc MC, Missir AV, Chirita IC, Caproiu MT:
Studies on the antimicrobial activity of new compounds containing
thiourea function. Biointerface Res App Chem 2011, 1(6):236–241.
30. Grumezescu AM, Mihaiescu DE, Mogoşanu DE, Chifiriuc MC, Lazar V, Lazar V,
Calugarescu I, Traistaru V: In vitro assay of the antimicrobial activity of
Fe3O4 and CoFe2O4/oleic acid - core/shell on clinical isolates of bacterial
and fungal strains. Optoelectron Adv Mat 2010, 4(11):1798–1801.
31. Chifiriuc C, Lazar V, Bleotu C, Calugarescu I, Grumezescu AM, Mihaiescu DE,
Mogoşanu DE: Bacterial adherence to the cellular and inert substrate in
the presence of CoFe2O4 and Fe3O4/oleic acid - core/shell. Dig J
Nanomater Bios 2011, 6(1):37–42.
32. Saviuc C, Grumezescu AM, Oprea E, Radulescu V, Dascalu L, Chifiriuc MC,
Bucur M, Banu O, Lazar V: Antifungal activity of some vegetal extracts on
Candida biofilms developed on inert substratum. Biointerface Res App
Chem 2011, 1(1):015–023.
33. Saviuc C, Grumezescu AM, Chifiriuc MC, Bleotu C, Stanciu G, Hristu R,
Mihaiescu D, Lazar V: In vitro methods for the study of microbial biofilms.
Biointerface Res App Chem 2011, 1(1):031–040.
34. Lutterotti L: Total pattern fitting for the combined size–strain–stress–
texture determination in thin film diffraction. Nuclear Inst. and Methods in
Physics Research B 2010, 268:334–340.
Ciobanu et al. Nanoscale Research Letters 2012, 7:324 Page 9 of 9
http://www.nanoscalereslett.com/content/7/1/32435. Popa NC: The (hkl) dependence of diffraction-line broadening caused by
strain and size for all Laue groups in Rietveld refinement. J. Appl. Cryst.
1998, 31:176–180.
36. Predoi D, Ghita RV, Ungureanu F, Negrila CC, Vatasescu-Balcan RA, Costache
M: Characteristics of hydroxyapatite thin films. J Optoelectron Adv Mater
2007, 9(12):3827–3831.
37. Predoi D, Barsan M, Andronescu E, Vatasescu-Balcan RA, Costache M:
Hydroxyapatite - iron oxide bioceramic prepared using nano-size
powders. J Optoelectron Adv Mater 2007, 9(11):3609–3613.
38. Costescu A, Pasuk I, Ungureanu F, Dinischiotu A, Costache M, Huneau F,
Galaup S, Le Coustumer P, Predoi D: Physico-chemical properties of
nano-sized hexagonal hydroxyapatite powder synthesized by sol–gel.
Dig J Nanomater Bios 2010, 5:989–1000.
39. Ciobanu CS, Andronescu E, Vasile BS, Valsangiacom CM, Ghita RV, Predoi D:
Looking for new synthesis of hydroxyapatite doped with europium.
Optoelectron Adv Mat 2010, 4:1515–1519.
40. Bai X, More K, Rouleau CM, Rabiei A: Functionally graded hydroxyapatite
coatings doped with antibacterial components. Acta Biomater 2010,
6:2264–2273.
41. Doat A, Pelle F, Gardant N, Lebugle A: Synthesis of luminescent bioapatite
nanoparticles for utilization as a biological probe. J Solid State Chem 2004,
177:1179–1187.
42. Elliot J: Structural and Chemistry of Apatites and other Calcium
Ortophosphates. Amsterdam: Elsevier; 1994.
43. Ogston A: Classics in infectious diseases. “On abscesses”. Rev Infect Dis
1984, 6(1):122–128.
44. Wang JT, Chang SC, Chen YC, Luh KT: Comparison of antimicrobial
susceptibility of Citrobacter freundii isolates in two different time periods.
J Microbiol, Immunol 2000, 33(4):258–262.
45. Lin CH, Huang HT, Chien CC, Tzeng DS, Lung FW: Purple urine bag
syndrome in nursing homes: ten elderly case reports and a literature
review. Clin Interv Aging 2008, 3(4):729–734.
46. Whalen JG, Mully TW, English JC: Spontaneous Citrobacter freundii
infection in an immunocompetent patient. Arch Dermatol 2007, 143
(1):124–125.
47. Podschun R, Ullman U: Klebsiella spp. as nosocomial pathogens:
epidemiology, taxonomy, typing methods, and pathogenicity factors.
Clin Microbiol Rev 1998, 11(4):589–603.
48. Hejazi A, Falkiner FR: Serratia marcescens. J Med Microbiol 1997,
46(11):903–912.
49. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S: Synthesis and effect of
silver nanoparticles on the antibacterial activity of different antibiotics
against Staphylococcus aureus and Escherichia coli. Nanomed-Nanotechnol
2007, 3:168–171.
50. Guzman M, Dille J, Godet S: Synthesis and antibacterial activity of silver
nanoparticles against gram-positive and gram-negative bacteria.
Nanomedicine 2012, 8:37–45.
51. Mirzajani F, Ghassempour A, Aliahmadi A, Ali Esmaeili M: Antibacterial
effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol 2011,
162:542–549.
52. Brigita T, Barbara S, Boris O: Antimicrobial activity of AgCl embedded in a
silica matrix on cotton fabric. Carbohyd Polym 2009, 75:618.
doi:10.1186/1556-276X-7-324
Cite this article as: Ciobanu et al.: Antibacterial activity of silver-doped
hydroxyapatite nanoparticles against gram-positive and gram-negative
bacteria. Nanoscale Research Letters 2012 7:324.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
